|
End-of-day quote
Shenzhen S.E.
2026-09-30
|
5-day change | 1st Jan Change | ||
| 8.550 CNY | -.--% |
|
+2.03% | -13.81% |
| 08-25 | Guiyang Xintian Pharmaceutical Co.,Ltd. Reports Earnings Results for the Half Year Ended June 30, 2026 | CI |
| 05-07 | Guiyang Xintian says key shareholder plans to unload up to about 3% stake | RE |
| Market Cap | 2.03B 303M 270M 252M 229M 432M 29.2B 435M 3.04B 1.18B 14.9B 1.14B 1.11B 47.9B | P/E 2024 |
39.9x | P/E 2025 | 256x |
|---|---|---|---|---|---|
| Enterprise Value | 2.53B 377M 336M 313M 285M 537M 36.31B 541M 3.79B 1.47B 18.53B 1.42B 1.38B 59.57B | EV / Sales 2024 |
3.07x | EV / Sales 2025 | 3.77x |
| Free-Float |
66.83% | Yield 2024 |
1.06% | Yield 2025 | 0.3% |
| 1 week | +2.03% | ||
| 1 month | +1.66% | ||
| 3 months | +8.23% | ||
| 6 months | -20.98% | ||
| Current year | -13.81% |
| 1 week | 8.3 |  | 8.65 |
| 1 month | 7.84 | | 8.69 |
| Current year | 7.04 | | 13.09 |
| 1 year | 7.04 | | 13.09 |
| 3 years | 7.04 | | 15.19 |
| 5 years | 7.04 | | 20.12 |
| 10 years | 6.63 | | 20.12 |
| Manager | Title | Age | Since |
|---|---|---|---|
Da Lun Dong
CEO | Chief Executive Officer | 62 | 2005-04-30 |
Zhi Hui Zeng
DFI | Director of Finance/CFO | 53 | 2019-11-03 |
Zhong Lei He
PRN | Corporate Officer/Principal | 49 | 2021-03-31 |
| Director | Title | Age | Since |
|---|---|---|---|
Da Lun Dong
CHM | Chairman | 62 | 2001-11-30 |
Jin Hua Wang
BRD | Director/Board Member | 59 | 1995-08-10 |
Wen Yi Wang
BRD | Director/Board Member | 53 | 2013-04-07 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 6/2/20 | Sell | Director | 21,000 | 0.0341% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -.--% | +2.03% | -20.02% | -33.15% | 303M | |
| +0.62% | -3.06% | +35.92% | +112.12% | 1,019B | |
| -1.10% | -6.93% | +34.51% | +61.06% | 617B | |
| +0.36% | -1.01% | +14.51% | +78.77% | 464B | |
| -3.13% | -5.87% | +57.61% | +35.09% | 356B | |
| +0.93% | -1.83% | +20.98% | +41.43% | 333B | |
| +0.12% | -4.05% | +10.09% | +33.53% | 267B | |
| -0.89% | -5.83% | -7.56% | +7.91% | 244B | |
| -0.00% | -3.74% | +36.84% | +51.83% | 218B | |
| -0.37% | -5.42% | +26.75% | +92.72% | 179B | |
| Average | -0.43% | -3.07% | +20.96% | +48.13% | 369.75B | |
| Weighted average by Cap. | -0.32% | -3.54% | +28.61% | +68.58% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 858M 128M 114M 106M 96.74M 182M 12.32B 184M 1.28B 500M 6.29B 480M 470M 20.21B | 750M 112M 99.76M 92.94M 84.58M 159M 10.77B 160M 1.12B 437M 5.5B 420M 411M 17.67B |
| Net income | 52.32M 7.8M 6.96M 6.49M 5.9M 11.12M 752M 11.2M 78.37M 30.49M 384M 29.3M 28.66M 1.23B | 9.11M 1.36M 1.21M 1.13M 1.03M 1.94M 131M 1.95M 13.65M 5.31M 66.8M 5.1M 4.99M 215M |
| Net Debt | 442M 65.91M 58.8M 54.78M 49.85M 93.88M 6.35B 94.57M 662M 258M 3.24B 247M 242M 10.41B | 495M 73.84M 65.88M 61.37M 55.85M 105M 7.11B 106M 742M 289M 3.63B 277M 271M 11.67B |
Employees
1,388
Sector
Pharmaceuticals
Calendar
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-09-30 | CN¥8.550 | -.--% | 3,006,316 |
| 26-09-29 | CN¥8.550 | +1.30% | 5,191,375 |
Annual profits - Rate of surprise
- Stock Market
- Stocks
- 002873 Stock
Select your edition
All financial news and data tailored to specific country editions
